A phase I/II Trial of CRISPR-Cas9-mediated PD-1 knockout EpsteinBarr virus cytotoxic lymphocytes (EBV-CTLs) for advanced stage EBV associated malignancies - Trial in progress
Annals of Oncology（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined